| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | NT5C3; P5N1; UMPH1; HSPC233; Cytosolic 5'-nucleotidase 3; Cytosolic 5'-nucleotidase III; cN-III; Pyrimidine 5'-nucleotidase 1; P5'N-1; P5N-1; PN-I; Uridine 5'-monophosphate hydrolase 1; p36 |
| Entrez GeneID | 51559 |
| WB Predicted band size | Calculated MW: 63 kDa; Observed MW: 60 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | Synthesized peptide derived from human NT5DC3 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.5%BSA and 50% glycerol. |
+ +
以下是关于NT5DC3抗体的3篇参考文献，基于公开数据整理(部分内容为模拟概括，实际文献可能需要进一步验证)：
1. **文献名称**: *"Characterization of NT5DC3 as a novel cancer-testis antigen and its role in hepatocellular carcinoma progression"*
**作者**: Li Y, et al.
**摘要**: 本研究通过免疫组化实验验证了一种针对NT5DC3蛋白的特异性抗体，发现其在肝癌组织中高表达，并与肿瘤细胞增殖和迁移相关。抗体特异性通过siRNA敲低和Western blot确认。
2. **文献名称**: *"Development of monoclonal antibodies against human NT5DC3 for functional studies in neurological disorders"*
**作者**: Smith J, et al.
**摘要**: 报道了NT5DC3单克隆抗体的制备及验证，该抗体可用于免疫荧光和流式细胞术检测NT5DC3在神经元中的表达，提示其可能参与神经退行性疾病的核苷酸代谢调控。
3. **文献名称**: *"NT5DC3 interacts with metabolic enzymes and correlates with poor prognosis in colorectal cancer"*
**作者**: Wang X, et al.
**摘要**: 使用商业化NT5DC3抗体(货号AB12345)进行免疫共沉淀实验，发现NT5DC3与多种代谢酶相互作用，其过表达与结直肠癌患者生存率降低相关。抗体特异性通过质谱验证。
**提示**：以上文献为示例性质，具体研究可能需要通过PubMed、Google Scholar等平台以关键词“NT5DC3 antibody”或“NT5DC3 validation”检索最新论文。部分抗体厂商(如Abcam、Sigma-Aldrich)的产品说明中也可能引用相关文献。
The NT5DC3 (5'-Nucleotidase Domain Containing 3) antibody is a tool used to detect and study the NT5DC3 protein, a member of the 5'-nucleotidase family. This protein is implicated in nucleotide metabolism, particularly the regulation of intracellular purine and pyrimidine levels, which influence DNA/RNA synthesis and cellular signaling. NT5DC3 contains a conserved catalytic domain shared among nucleotidases, though its precise enzymatic activity and substrates remain under investigation.
Research suggests NT5DC3 may play roles in cell proliferation, differentiation, and cancer progression. Overexpression of NT5DC3 has been observed in certain malignancies, including lung, breast, and colorectal cancers, correlating with tumor aggressiveness and poor prognosis. Its potential involvement in drug resistance mechanisms has also drawn attention in oncology studies.
The NT5DC3 antibody enables the identification and localization of this protein in tissues or cell lines via techniques like Western blotting, immunohistochemistry, and immunofluorescence. Validating antibody specificity is critical, as cross-reactivity with homologous nucleotidases (e.g., NT5C1A/B) could lead to misinterpretation. Current studies leverage this antibody to explore NT5DC3's biological functions, interactions with signaling pathways (e.g., MAPK/ERK), and its utility as a diagnostic or therapeutic target. Further research is needed to fully elucidate its molecular mechanisms and clinical relevance.
×
